安全监测

用于高基体氧化镧样品中元素杂质定量分析的ICP-MS方法研究

  • 沈萌萌 ,
  • 杨秀云 ,
  • 肖超强 ,
  • 朱俐
展开
  • 1.河南科技职业大学, 周口 466000;
    2.北京达因高科儿童药物研究院有限公司, 北京 100176;
    3.中国食品药品检定研究院, 北京 102629
第一作者 Tel:18272986371;E-mail:936223777@qq.com
*肖超强 Tel:(010)67832191;E-mail:xiaochaoqiang@dynemed.com;朱 俐 Tel:(010)53851549;E-mail:zhuli@nifdc.org.cn

收稿日期: 2024-06-28

  网络出版日期: 2025-01-07

Research on ICP-MS method for quantitative analysis of elemental impurities in high matrix lanthanum oxide samples

  • SHEN Meng-meng ,
  • YANG Xiu-yun ,
  • XIAO Chao-qiang ,
  • ZHU Li
Expand
  • 1. Henan Vocational University of Science and Technology, Zhoukou 466000, China;
    2. Beijing Dyne High-tech Pediatric Pharmaceutical R&D Institute, Beijing 100176, China;
    3. National Institutes for Food and Drug Control, Beijing 102629, China

Received date: 2024-06-28

  Online published: 2025-01-07

摘要

目的: 建立氧化镧中元素杂质检测的ICP-MS方法,探讨用于高基体样品定量分析的ICP-MS方法开发。方法: 称取样品25 mg,置25 mL量瓶中,加硝酸1 mL和盐酸溶液0.25 mL,振摇,消解约1 h,用超纯水定容。采用Agilent 7900 ICP-MS以He模式用内标校正的标准曲线法进行样品定量测定,雾化气流速1.05 L·min-1,雾化室温度2 ℃,样品提升速度0.1 r·s-1,射频功率为1 550 W,采样深度10 mm,氦气流速5 mL·min-1,能量歧视5.0 V。依据ICH Q2(R2)和USP 2023 <233>采用加标回收率表征方法专属性,建立25种元素杂质的定量方法。以加标样品中各元素的同位素比进行专属性研究,进行待测元素的质量数选择,并完成方法验证。结果: 根据专属性考察结果Se和Ce选择82和142为检测质量数以避免干扰。方法验证结果表明24种元素杂质的线性关系良好,回收率均在70%~150%,重复性RSD≤20%,方法满足质控要求。多批次样品中检出Pb(0.152~0.201 ng·g-1)、Cd(0.007~0.010 ng·g-1)、Hg(0.156~0.250 ng·g-1)等杂质,各元素杂志的含量均低于拟定标准。结论: 本方法专属性强,准确度高,简便可行,可以为氧化镧的元素杂质控制提供技术支撑。对复杂高基体样品,加标回收率存在不足以表征方法的专属性和准确性的情况,同位素比可作为加标回收率的补充手段。

本文引用格式

沈萌萌 , 杨秀云 , 肖超强 , 朱俐 . 用于高基体氧化镧样品中元素杂质定量分析的ICP-MS方法研究[J]. 药物分析杂志, 2024 , 44(10) : 1772 -1779 . DOI: 10.16155/j.0254-1793.2024-0432

Abstract

Objective: To establish an ICP-MS method for the detection of elemental impurities in lanthanum oxide and to explore the development of the ICP-MS methodology for high-matrix samples quantitative analysis. Methods: 25 mg samples were precisely weighed and placed in a 25 mL flask. 1 mL of nitric acid and 0.25 mL of hydrochloric acid solution were added, shaken, and dissolved for approximately 1 h, then fixed with ultrapure water. Quantitative samples determination were performed using Agilent 7900 ICP-MS in He mode with the standard curve method corrected by internal standard. The atomizing gas flow rate was set at 1.05 L·min-1, the atomizing chamber temperature was maintained at 2 ℃, the sample aspiration rate was 0.1 r·s-1, the RF power was 1 550 W, and the sampling depth was 10 mm. The helium flow rate was 5 mL·min-1, and the energy discrimination was 5.0 V. Based on ICH Q2 (R2) and USP 2023 <233>, a quantitative method for 25 elemental impurities was established by utilizing the recovery rate of the method. The isotope ratio of each element in the sample was investigated, the mass number of the element to be measured was selected, and the method was verified. Results: Based on the specific outcomes of Se and Ce, 82 and 142 were chosen as the detection mass numbers to evade interference. The results demonstrated that the linear relationships of the 24 elemental impurities were excellent, the recoveries ranged from 70% to 150%, the repeatability RSDs were less than 20%, and the method satisfied the quality control requirements. Impurities such as Pb (0.152-0.201 ng·g-1), Cd (0.007-0.010 ng·g-1), Hg (0.156-0.250 ng·g-1) were detected in numerous batches of samples, and the contents of each element were lower than the proposed standard. Conclusion: The method is specific, accurate, simple, and feasible, and can furnish technical support for the elemental impurity control of lanthanum oxide. For complex and high-matrix samples, the recovery rate of standard addition is inadequate to characterize the specificity and accuracy of the method, and the isotope ratio can be utilized as a supplement to the recovery rate of standard addition.

参考文献

[1] 姜小林, 董素萍, 舒靖能. ICH Q3D新药制剂元素杂质评估及控制的要点解读[J]. 中国药事, 2017, 31(8):854
JIANG XL, DONG SP, SHU JN. Interpretation of key points of assessment and control of elemental impurities in new drug preparation for ICH Q3D guideline[J]. Chin Pharm Aff, 2017, 31(8):854
[2] XIAO C, ZHU L, ZHANG X, et al. Elemental impurities in pediatric calcium carbonate preparations-high throughput quantification and risk assessment[J]. Front Chem, 2021, 9: 682798
[3] ZHU L, XIAO C, TENG X, et al. An inductively coupled plasma mass spectrometry method for the determination of elemental impurities in calcium carbonate mineral medicine[J]. Spectrochim Acta Part B-Atom Spectrosc, 2022, (192):388
[4] JANCHEVSKA K, STAFILOV T, MEMED-SEJFULAH S, et al. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake—comparative analysis by ICP-OES and ICP-MS[J]. Drug Dev Ind Pharm, 2020, 46(3):456
[5] MAITHANI M, RATURI R, SHARMA P, et al. Elemental impurities in pharmaceutical products adding fuel to the fire[J]. Regul Toxicol Pharmacol, 2019, 108: 104435
[6] MITTAL M, KUMAR K, ANGHORE D, et al. ICP-MS: analytical method for identification and detection of elemental impurities[J]. Curr Drug Discov Technol, 2017, 14(2):106
[7] International Conference on Harmonisation. Validation of analytical procedures Q2(R2) [EB/OL]. [2024-06-01]. https://database. ich. org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130. pdf
[8] USP 46-NF 41[S]. 2023: <233>
[9] CHAHROUR O, MALONE J, COLLINS M, et al. Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP <232>/<233>[J]. J Pharm Biomed Anal, 2017, 145: 84
[10] 王静文, 徐代月, 陈华, 等. 盐酸罗哌卡因注射液中29种元素杂质的含量测定[J]. 药物分析杂志, 2023, 43(5):849
WANG JW, XU DY, CHEN H, et al. Determination of 29 elemental impurities in ropivacaine hydrochloride injection[J]. Chin J Pharm Anal, 2023, 43(5):849
[11] 张凤妹, 陈丹丹, 顾霄, 等. 注射用头孢美唑钠中10种ICH控制元素测定方法的建立[J]. 药物分析杂志, 2023, 43(8):1446
ZHANG FM, CHEN DD, GU X, et al. A method for the determination of 10 elemental impurities in cefmetazole sodium for injection according to ICH requirement[J]. Chin J Pharm Anal, 2023, 43(8):1446
[12] 李昊, 管清磊, 郑文凤, 等. 亚甲蓝原料药中17种元素杂质含量测定[J]. 药物分析杂志, 2022, 11: 1954
LI H, GUAN QL, ZHENG WF, et al. Assay determination of 17 elemental impurities in methylene blue APIs[J]. Chin J Pharm Anal, 2022, 11: 1954
[13] 钟思伟. ICP-MS法测定左氧氟沙星注射液中10种元素杂质的含量[J]. 药物分析杂志, 2023, 43(11):1914
ZHONG SW. Determination of 10 elemental impurities in levofloxacin injection by ICP-MS[J]. Chin J Pharm Anal, 2023, 43(11):1914
[14] 沈湉湉, 张兵, 李烨, 等. ICP-MS基体匹配法测定酮咯酸氨丁三醇注射液中11种元素杂质迁移量[J]. 药物分析杂志, 2024, 44(2):316
SHEN TT, ZHANG B, LI H, et al. Determination of migration of eleven elemental impurities in ketorolac tromethamine injection by ICP-MS with matrix-matching method[J]. Chin J Pharm Anal, 2024, 44(2):316
[15] International Conference on Harmonisation. Guideline for element impurities Q3D (R2) [EB/OL]. [2024-06-01]. https://database. ich. org/sites/default/files/Q3D-R2_Guideline_Step4_2022_0308. pdf
[16] 任锟, 郭燕燕, 王晓兰, 等. 电感耦合等离子质谱法测定碳酸镧原料药中24种元素杂质含量[J]. 药物分析杂志, 2021, 41(11):11
REN K, GUO YY, WANG XL, et al. Determination of 24 element impurities in lanthanum carbonate API by inductively coupled plasma mass spectrometry[J]. Chin J Pharm Anal, 2021, 41(11):11
[17] 中华人民共和国药典 2020年版. 四部[S]. 2020: 481
ChP 2020. Vol Ⅳ[S]. 2020: 481
[18] 王小如. 电感耦合等离子体质谱应用实例[M]. 北京: 化学工业出版社, 2005
WANG XR. Application Example of Inductively Coupled Plasma Mass Spectrometry[M]. Beijing: Chemical Industry Press, 2005
文章导航

/